Literature DB >> 24966968

Diagnostic utility of E-cadherin and P120 catenin cocktail immunostain in distinguishing DCIS from LCIS.

Xiaoxian Li1, Mary R Schwartz2, Jae Ro3, Candice R Hamilton2, Alberto G Ayala3, Luan D Truong3, Qihui Jim Zhai4.   

Abstract

BACKGROUND: Breast carcinoma in situ (CIS) is classified into ductal carcinoma in situ (DCIS) and lobular carcinoma in situ (LCIS). DCIS is treated with surgical excision while LCIS can be clinically followed with or without hormonal treatment. Thus, it is critical to distinguish DCIS from LCIS. Immunohistochemical (IHC) staining for E-cadherin is routinely used to differentiate DCIS from LCIS in diagnostically challenging cases. Circumferential diffuse membranous staining of E-cadherin is the typical pattern in DCIS, whereas LCIS lacks or shows decreased E-cadherin expression. Recent studies have shown that DCIS has membranous staining of P120 catenin and LCIS has diffuse cytoplasmic staining of P120 catenin. We developed a cocktail composed of E-cadherin and P120 catenin primary antibodies so that only one slide is needed for the double immunostains. DESIGNS: Twenty-seven blocks of formalin-fixed paraffin-embedded tissue from 26 cases of DCIS or LCIS were retrieved from the archives of Houston Methodist Hospital. Four consecutive sections from the same blocks were used for H&E and immunohistochemical (IHC) stains. The E-cadherin antibody was a rabbit polyclonal antibody and the P120 catenin antibody was a mouse monoclonal antibody. The E-cadherin primary antibody was detected using a secondary antibody raised against rabbit antibody and was visualized with a brown color. The P120 catenin primary antibody was detected using a secondary antibody raised against mouse antibody and was visualized with a red color.
RESULTS: Using individual antibodies, 15 of 15 DCIS lesions had diffuse circumferential membranous E-cadherin staining (brown stain) or P120 catenin staining (red stain). All 12 LCIS cases showed cytoplasmic P120 red staining or loss of E-cadherin staining when the single P120 catenin or E-cadherin antibody was used. When stained with the antibody cocktail, all 15 DCIS samples showed diffuse red and brown membranous staining without cytoplasmic stain; all 12 LCIS samples showed diffuse cytoplasmic red staining for P120 catenin but no membranous staining for E-cadherin.
CONCLUSIONS: 1. This antibody cocktail can be applied in daily practice on paraffin-embedded tissue and is especially useful in small biopsies with small foci of CIS lesions. 2. Immunohistochemical staining with the antibody cocktail showed 100% concordance with the traditional single antibody immunostaining using either E-cadherin or P120 catenin antibody. 3. Our antibody cocktail includes E-cadherin as a positive membranous stain for DCIS and P120 catenin as a positive cytoplasmic stain for LCIS, which may enhance accuracy and confidence in the differential diagnoses.

Entities:  

Keywords:  DCIS; E-cadherin; LCIS; p120 catenin

Mesh:

Substances:

Year:  2014        PMID: 24966968      PMCID: PMC4069889     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

1.  An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.

Authors:  Schuyler O Sanderson; Thomas J Sebo; Linda M Murphy; Roxann Neumann; Jeff Slezak; John C Cheville
Journal:  Am J Clin Pathol       Date:  2004-02       Impact factor: 2.493

2.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

Authors:  S R Wellings; H M Jensen; R G Marcum
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

3.  Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision.

Authors:  Andrew A Renshaw; Robert P Derhagopian; Pilar Martinez; Edwin W Gould
Journal:  Am J Clin Pathol       Date:  2006-08       Impact factor: 2.493

4.  Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.

Authors:  Tarik M Elsheikh; Jan F Silverman
Journal:  Am J Surg Pathol       Date:  2005-04       Impact factor: 6.394

5.  Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.

Authors:  Nour Sneige; Jianzhou Wang; Barbara A Baker; Savitri Krishnamurthy; Lavinia P Middleton
Journal:  Mod Pathol       Date:  2002-10       Impact factor: 7.842

6.  Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.

Authors:  G L Ottesen; H P Graversen; M Blichert-Toft; I J Christensen; J A Andersen
Journal:  Breast Cancer Res Treat       Date:  2000-08       Impact factor: 4.872

7.  Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?

Authors:  Lavinia P Middleton; Shakeitha Grant; Tanya Stephens; Carol B Stelling; Nour Sneige; Aysegul A Sahin
Journal:  Mod Pathol       Date:  2003-02       Impact factor: 7.842

8.  Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.

Authors:  Ming Zhou; Rajal Shah; Ronglai Shen; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2003-03       Impact factor: 6.394

Review 9.  Overview of the biology and management of ductal carcinoma in situ of the breast.

Authors:  E R Frykberg; K I Bland
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

10.  The significance of lobular neoplasia on needle core biopsy of the breast.

Authors:  S Menon; G J R Porter; A J Evans; I O Ellis; C W Elston; Z Hodi; A H S Lee
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

View more
  2 in total

1.  Prognostic and predictive significance of tumor infiltrating lymphocytes for ductal carcinoma in situ.

Authors:  Fei-Fei Xu; Sai-Fang Zheng; Cheng Xu; Gang Cai; Shu-Bei Wang; Wei-Xiang Qi; Chao-Fu Wang; Jia-Yi Chen; Cao Lu
Journal:  Oncoimmunology       Date:  2021-03-18       Impact factor: 8.110

2.  Clonal relationships between lobular carcinoma in situ and other breast malignancies.

Authors:  Colin B Begg; Irina Ostrovnaya; Jose V Scarpa Carniello; Rita A Sakr; Dilip Giri; Russell Towers; Michail Schizas; Marina De Brot; Victor P Andrade; Audrey Mauguen; Venkatraman E Seshan; Tari A King
Journal:  Breast Cancer Res       Date:  2016-06-23       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.